Three Big Readouts To Close Out Roche’s Year Of Rebuilding
Potential blockbusters in the Alzheimer’s, Parkinson’s and lung cancer fields will produce much-awaited results this quarter, as the Swiss major reported solid Q3 growth.

Potential blockbusters in the Alzheimer’s, Parkinson’s and lung cancer fields will produce much-awaited results this quarter, as the Swiss major reported solid Q3 growth.